Clinical trial
A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve
NCT05941455 is registered in ClinicalTrials.gov with Jilin Venus Haoyue Medtech Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve
- Lead sponsor
- Jilin Venus Haoyue Medtech Limited
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2023
- Completion date
- October 31, 2029
- Enrollment
- 155 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.